See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

Multi-Talented Diabetes Educator Is a Joy to the World

Joy Pape, RN, BSN, CDE, WOCN, CFCN

Multi-Talented Diabetes Educator Is a Joy to the World

First Look:  New iPhone App for Logging Readings and Much More

Hadi El Heneidi - Agamatrix

First Look: New iPhone App for Logging Readings and Much More

Dr. Sheri Colberg Interviewed by Scott King

Dr. Sheri Colberg

Dr. Sheri Colberg Interviewed by Scott King

Diabetes Medication Archives

Diabetes Medication

Updated 84 weeks ago
 
FDA Approves New Neuropathy Pain Drug

The US Food and Drug Administration has approved US sales of NUCYNTA® ER (tapentadol), a twice-daily extended-release oral analgesic for the treatment of pain from diabetic peripheral neuropathy. The drug, produced by New Jersey-based Janssen Pharmaceuticals, Inc., provides around-the-clock management for moderate to severe chronic neuropathic pain. Janssen says that it is currently the only opioid on the US market that has been approved for treating the condition.

Comments 1 comment - Sep 11, 2012 - * * * * *

Newly Diagnosed with Type 2 Diabetes? Be Sure Your Doctor Prescribes a Generic First

According to a study of patients newly diagnosed with type 2 diabetes, 35 percent of the time their physicians did not follow the American Diabetes Association (ADA) guideline that calls for prescribing a generic drug first. The study, conducted by researchers from CVS Caremark, Harvard University, and Brigham and Women's Hospital, reviewed the pharmacy claims of 254,000 patients who were started on a diabetes medication in January 2006 and December 2008. One-third of the treatment regimens did not adhere to the ADA guideline.

Comments 0 comments - Mar 13, 2012 - * * * * *

 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.